Conceptual models of drug-drug interactions: A summary of recent efforts

被引:10
|
作者
Herrero-Zazo, Maria [1 ]
Segura-Bedmar, Isabel [2 ]
Martinez, Paloma [2 ]
机构
[1] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England
[2] Univ Carlos III Madrid, Dept Comp Sci, Leganes 28911, Spain
关键词
Drug-drug interactions; Conceptual modeling; Knowledge representation; Ontology; Natural language processing; Computational inference; ONTOLOGY; KNOWLEDGE; EXTRACTION; SYSTEM; PHARMACOVIGILANCE; INFORMATION; FRAMEWORK; LABELS;
D O I
10.1016/j.knosys.2016.10.006
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Conceptual modeling elicits and describes general knowledge in a particular domain and is a fundamental step in the development of knowledge-based systems. However, different conceptual models (CMs) could represent the same domain because they result from human intellectual activity with different objectives. Analyzing previous related efforts is crucial when conceptualizing a domain to avoid duplication, increase interoperability and ensure scientific conformity. Our domain of interest is drug-drug interactions (DDIs), and here we review 15 studies that have attempted total or partial representation of the DDI domain. Direct comparison of these different conceptualizations is complex because CMs are usually not provided, differ considerably from each other or are described with diverse formalisms at different abstraction levels. Therefore, to compare these CMs, we represent all of them in a common representation framework. Here, we compare the scope, content, final implementation and applications of CMs of the DDI domain. We aim to identify which aspects of DDIs have been conceptualized, characterize how this information has been modeled by different research groups, describe how each CM has been translated and illustrate the applications generated from the final models. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 50 条
  • [1] Recent development of machine learning models for the prediction of drug-drug interactions
    Hong, Eujin
    Jeon, Junhyeok
    Kim, Hyun Uk
    [J]. KOREAN JOURNAL OF CHEMICAL ENGINEERING, 2023, 40 (02) : 276 - 285
  • [2] Recent development of machine learning models for the prediction of drug-drug interactions
    Eujin Hong
    Junhyeok Jeon
    Hyun Uk Kim
    [J]. Korean Journal of Chemical Engineering, 2023, 40 : 276 - 285
  • [3] DRUG-DRUG INTERACTIONS
    FORTH, W
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA1): : 108 - 114
  • [4] Drug-drug interactions
    Preskorn, SH
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (05) : 223 - 225
  • [5] Evaluation of models for predicting drug-drug interactions due to induction
    Fahmi, Odette A.
    Ripp, Sharon L.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1399 - 1416
  • [6] Absorption Models to Examine Bioavailability and Drug-Drug Interactions in Humans
    Rizwan, Ahsan Naqi
    Brouwer, Kim L. R.
    [J]. ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 343 - 370
  • [7] Drug-drug interactions in man:: predictive value of in vitro models
    Weber, F
    Becquemont, L
    [J]. THERAPIE, 2000, 55 (04): : 569 - 575
  • [8] Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions
    Cami, Aurel
    Manzi, Shannon
    Arnold, Alana
    Reis, Ben Y.
    [J]. PLOS ONE, 2013, 8 (04):
  • [9] Dealing with the complex drug-drug interactions: Towards mechanistic models
    Varma, Manthena V.
    Pang, K. Sandy
    Isoherranen, Nina
    Zhao, Ping
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (02) : 71 - 92
  • [10] Use of In Vivo Animal Models to Assess Drug-Drug Interactions
    Prueksaritanont, Thomayant
    [J]. ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 283 - 297